Avadel Pharmaceuticals plc. (AVDL) NASDAQ

$15.99 0.03 (0.19%)

Market Cap: $1.45B

As of 04/12/24 04:00 PM EDT. Market closed.

(AVDL)

Avadel Pharmaceuticals plc. (AVDL)
NASDAQ

$15.99
0.03 (0.19%)

Market Cap: $1.45B

As of 04/12/24 04:00 PM EDT. Market closed.

Add to Portfolio

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and ... read more

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Gregory Divis
Full Time Employees
144
URL
Address
Block 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Dublin, 15.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Gregory Divis
Full Time Employees
144
Address
Block 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Dublin, 15.
PRICE CHART FOR AVADEL PHARMACEUTICALS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.75
Previous Close
$15.96
Days Range
$15.32 - $16
52 week range
$9.50 - $17.44
Volume
1,465,950
Avg. Volume (30 days)
651,449
Market Cap
$1.45B
Dividend Yield
-
P/E
-
Shares Outstanding
90,576,998
Open
$15.75
Previous Close
$15.96
Days Range
$15.32 - $16
52 week range
$9.50 - $17.44
Volume
1,465,950
Avg. Volume (30 days)
651,449
Market Cap
$1.45B
Dividend Yield
-
P/E
-
Shares Outstanding
90,576,998
FINANCIAL STATEMENTS FOR AVADEL PHARMACEUTICALS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AVADEL PHARMACEUTICALS PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MCHUGH THOMAS SChief Financial OfficerJan 16, 2024 Buy$14.502,00029,00080,500Jan 16, 2024, 04:36 PM
McCamish Mark AnthonyDirectorDec 28, 2023 Sale$14.5375,0001,089,75067,025Dec 29, 2023, 04:15 PM
McCamish Mark AnthonyDirectorAug 11, 2023 Sale$14.9328,975432,614142,025Aug 15, 2023, 04:13 PM
MCHUGH THOMAS SChief Financial OfficerAug 14, 2023 Buy$14.452,00028,90078,500Aug 14, 2023, 05:56 PM
Glass Geoffrey MichaelDirectorAug 10, 2023 Buy$13.4014,000187,60059,000Aug 11, 2023, 04:00 PM
Divis Gregory JChief Executive OfficerAug 10, 2023 Buy$13.2010,000131,997159,100Aug 10, 2023, 06:45 PM
Ende Eric JDirectorMay 18, 2023 Buy$13.9313,000181,100167,900May 19, 2023, 04:16 PM
Palczuk LindaDirectorMay 09, 2023 Buy$14.762,50036,90052,400May 10, 2023, 04:12 PM
Palczuk LindaDirectorDec 23, 2022 Buy$7.202,00014,40549,900Dec 28, 2022, 04:02 PM
MCHUGH THOMAS SChief Financial OfficerNov 29, 2022 Buy$7.805,00039,00076,500Nov 30, 2022, 04:01 PM
Ende Eric JDirectorNov 22, 2022 Buy$7.8020,000156,050154,900Nov 23, 2022, 04:01 PM
Glass Geoffrey MichaelDirectorMay 31, 2022 Buy$2.1445,00096,30045,000Jun 03, 2022, 06:05 PM
Glass Geoffrey MichaelDirectorJun 01, 2022 Buy$2.1445,00096,30045,000Jun 02, 2022, 04:02 PM
Ende Eric JDirectorMay 31, 2022 Buy$2.1615,00032,394114,900Jun 01, 2022, 06:59 PM
Ende Eric JDirectorJun 01, 2022 Buy$2.2720,00045,496134,900Jun 01, 2022, 06:59 PM
Palczuk LindaDirectorMay 27, 2022 Buy$1.6010,00016,00047,900May 31, 2022, 07:17 AM
MCHUGH THOMAS SChief Financial OfficerMay 27, 2022 Buy$2.1450,000106,89571,500May 31, 2022, 07:15 AM
Ende Eric JDirectorMay 27, 2022 Buy$2.4515,00036,74799,900May 31, 2022, 07:14 AM
Divis Gregory JChief Executive OfficerMay 27, 2022 Buy$2.0550,000102,500149,100May 31, 2022, 07:13 AM
Thornton Peter J.DirectorMay 27, 2022 Buy$1.6950,00084,50083,055May 31, 2022, 07:12 AM
MCHUGH THOMAS SChief Financial OfficerSep 18, 2020 Buy$6.004,00024,00021,500Sep 21, 2020, 04:01 PM
McCamish Mark AnthonyDirectorSep 17, 2020 Buy$5.8352,398305,250171,000Sep 18, 2020, 04:20 PM
McCamish Mark AnthonyDirectorSep 16, 2020 Buy$5.73118,602679,969118,602Sep 18, 2020, 04:20 PM
Ende Eric JDirectorSep 17, 2020 Buy$5.7917,00098,37684,900Sep 18, 2020, 04:19 PM
MCHUGH THOMAS SChief Financial OfficerAug 28, 2020 Buy$6.777,50050,77617,500Sep 01, 2020, 04:12 PM
Glass Geoffrey MichaelDirectorAug 28, 2020 Buy$6.784,80032,56065,700Sep 01, 2020, 04:11 PM
MCHUGH THOMAS SChief Financial OfficerAug 13, 2020 Buy$7.7810,00077,81410,000Aug 17, 2020, 06:59 PM
Palczuk LindaDirectorAug 14, 2020 Buy$7.942,50019,85037,900Aug 17, 2020, 06:58 PM
Ende Eric JDirectorAug 13, 2020 Buy$7.795,00038,92867,900Aug 17, 2020, 06:57 PM
Glass Geoffrey MichaelDirectorAug 13, 2020 Buy$7.766,50050,44060,900Aug 14, 2020, 06:11 PM
Glass Geoffrey MichaelDirectorAug 12, 2020 Buy$7.706,50050,05054,400Aug 14, 2020, 06:11 PM
Ende Eric JDirectorAug 12, 2020 Buy$7.7615,000116,35562,900Aug 13, 2020, 07:40 PM
Divis Gregory JChief Executive OfficerAug 12, 2020 Buy$7.7813,000101,15699,100Aug 13, 2020, 07:39 PM
Hatten Sandra LSee RemarksDec 12, 2019 Sale$7.233,07222,21155,765Dec 16, 2019, 04:21 PM
Ende Eric JDirectorDec 04, 2019 Buy$5.9710,00059,70047,900Dec 05, 2019, 04:30 PM
Palczuk LindaDirectorDec 03, 2019 Buy$5.917,50044,32535,400Dec 05, 2019, 04:29 PM
Glass Geoffrey MichaelDirectorNov 18, 2019 Buy$4.9915,00074,85047,900Nov 19, 2019, 05:03 PM
Glass Geoffrey MichaelDirectorNov 15, 2019 Buy$4.995,00024,95032,900Nov 19, 2019, 05:03 PM
DIVIS GREG JChief Executive OfficerNov 15, 2019 Buy$5.1319,00097,47086,100Nov 19, 2019, 05:00 PM
Ende Eric JDirectorNov 15, 2019 Buy$4.9810,00049,76237,900Nov 19, 2019, 04:46 PM
KANAN MICHAEL FSee RemarksDec 14, 2018 Sale$2.498,42921,02229,538Dec 18, 2018, 04:06 PM
GUSKY DAVID PController & CAODec 14, 2018 Sale$2.686171,6564,083Dec 18, 2018, 04:04 PM
Hatten Sandra LSee RemarksDec 14, 2018 Sale$2.583,1738,18340,837Dec 18, 2018, 04:01 PM
ANDERSON MICHAEL SChief Executive OfficerAug 10, 2018 Sale$4.9116,29779,953248,953Aug 14, 2018, 08:01 PM
Hatten Sandra LSee RemarksAug 10, 2018 Sale$4.916,29030,85944,010Aug 14, 2018, 08:00 PM
KANAN MICHAEL FSee RemarksJun 26, 2018 Buy$5.701,96711,21237,967Jun 29, 2018, 05:24 PM
ANDERSON MICHAEL SChief Executive OfficerJun 26, 2018 Buy$6.042,50015,100265,250Jun 27, 2018, 07:02 PM
DIVIS GREG JSee RemarksJun 26, 2018 Buy$6.0016,00096,00049,100Jun 27, 2018, 07:00 PM
THOMPSON PHILLANDAS T.See RemarksJun 26, 2018 Buy$5.7710,00057,70091,000Jun 27, 2018, 06:58 PM
Flynn James E10% OwnerJun 25, 2018 Sale$5.99114,034683,315952,265Jun 25, 2018, 05:59 PM
ANDERSON MICHAEL SChief Executive OfficerMay 24, 2018 Buy$6.443,00019,320262,750May 29, 2018, 05:15 PM
STAPLETON CRAIG RDirectorDec 15, 2017 Buy$8.6770,000606,970323,413Dec 19, 2017, 07:47 PM
STAPLETON CRAIG RDirectorDec 15, 2017 Buy$8.6770,000606,970180,000Dec 19, 2017, 07:47 PM
STAPLETON CRAIG RDirectorDec 15, 2017 Option Exercise$8.6770,000606,970180,000Dec 19, 2017, 04:09 PM
STAPLETON CRAIG RDirectorDec 15, 2017 Option Exercise$8.6770,000606,970323,413Dec 19, 2017, 04:09 PM
ANDERSON MICHAEL SChief Executive OfficerDec 07, 2017 Buy$8.865,00044,295234,750Dec 11, 2017, 04:10 PM
STAPLETON CRAIG RDirectorNov 27, 2017 Sale$9.35254,2652,377,632253,413Nov 29, 2017, 04:35 PM
Thornton Peter J.DirectorSep 21, 2017 Buy$9.745,15550,2155,155Sep 25, 2017, 04:58 PM
Hatten Sandra LSee RemarksSep 12, 2017 Buy$9.151,20010,9803,400Sep 15, 2017, 04:15 PM
Hatten Sandra LSee RemarksSep 14, 2017 Buy$9.362,10019,65437,800Sep 15, 2017, 04:15 PM
Hatten Sandra LSee RemarksSep 13, 2017 Buy$9.355004,67335,700Sep 15, 2017, 04:15 PM
Hatten Sandra LSee RemarksSep 12, 2017 Buy$9.192,20020,21835,200Sep 15, 2017, 04:15 PM
THOMPSON PHILLANDAS T.See RemarksSep 13, 2017 Buy$9.365,00046,80063,000Sep 14, 2017, 05:09 PM
STAPLETON CRAIG RDirectorSep 12, 2017 Buy$9.5220,000190,360110,000Sep 14, 2017, 05:06 PM
DIVIS GREG JSee RemarksSep 12, 2017 Buy$9.3210,60098,76010,600Sep 14, 2017, 05:03 PM
ANDERSON MICHAEL SChief Executive OfficerSep 12, 2017 Buy$9.804,00039,180229,750Sep 14, 2017, 04:58 PM
Broadfin Healthcare Master Fund Ltd10% OwnerJun 23, 2017 Sale$10.60161,0001,706,6004,133,464Jun 26, 2017, 04:45 PM
Broadfin Healthcare Master Fund Ltd10% OwnerJun 22, 2017 Sale$10.80100,0001,080,0004,294,464Jun 26, 2017, 04:45 PM
CERUTTI GUILLAUMEDirectorJun 15, 2017 Sale$10.4626,560277,81823,440Jun 19, 2017, 04:07 PM
ANDERSON MICHAEL SChief Executive OfficerMay 19, 2017 Buy$10.002,50025,000225,750May 22, 2017, 06:20 PM
STAPLETON CRAIG RDirectorMay 19, 2017 Buy$9.833,10030,47373,100May 22, 2017, 06:17 PM
STAPLETON CRAIG RDirectorMay 18, 2017 Buy$9.9811,013109,91070,000May 22, 2017, 06:17 PM
STAPLETON CRAIG RDirectorMay 22, 2017 Buy$9.7616,900164,94490,000May 22, 2017, 06:17 PM
STAPLETON CRAIG RDirectorMay 17, 2017 Option Exercise$9.9512,100120,39358,987May 18, 2017, 04:43 PM
STAPLETON CRAIG RDirectorMay 16, 2017 Option Exercise$10.003,47034,70046,887May 18, 2017, 04:43 PM
STAPLETON CRAIG RDirectorMay 15, 2017 Option Exercise$10.003113,11043,417May 16, 2017, 04:20 PM
STAPLETON CRAIG RDirectorMay 12, 2017 Option Exercise$10.003,10631,06043,106May 16, 2017, 04:20 PM
STAPLETON CRAIG RDirectorApr 04, 2017 Option Exercise$9.5815,000143,643507,678Apr 05, 2017, 06:52 PM
STAPLETON CRAIG RDirectorNov 29, 2016 Buy$10.8510,000108,50040,000Nov 30, 2016, 04:18 PM
STAPLETON CRAIG RDirectorNov 28, 2016 Buy$10.7410,000107,37030,000Nov 30, 2016, 04:18 PM
ANDERSON MICHAEL SChief Executive OfficerNov 21, 2016 Buy$10.642,00021,274193,250Nov 22, 2016, 05:01 PM
FILDES FRANCISDirectorSep 22, 2016 Sale$13.4515,000201,75015,000Sep 23, 2016, 04:44 PM
ANDERSON MICHAEL SChief Executive OfficerSep 02, 2016 Buy$14.122,00028,240191,250Sep 07, 2016, 06:58 PM
STAPLETON CRAIG RDirectorSep 01, 2016 Buy$13.5210,000135,190519,678Sep 06, 2016, 05:27 PM
STAPLETON CRAIG RDirectorAug 26, 2016 Buy$13.7620,000275,14020,000Aug 29, 2016, 04:11 PM
ANDERSON MICHAEL SChief Executive OfficerAug 22, 2016 Buy$14.305,00071,479189,250Aug 22, 2016, 04:53 PM
STAPLETON CRAIG RDirectorMay 16, 2016 Buy$9.252,41522,339509,678May 16, 2016, 04:40 PM
STAPLETON CRAIG RDirectorMay 13, 2016 Buy$9.2124,813228,553507,263May 16, 2016, 04:40 PM
ANDERSON MICHAEL SChief Executive OfficerMay 12, 2016 Buy$8.845,00044,200134,250May 16, 2016, 04:39 PM
THOMPSON PHILLANDAS T.See RemarksMar 22, 2016 Buy$11.1010,000111,03020,000Mar 22, 2016, 06:38 PM
ANDERSON MICHAEL SChief Executive OfficerMar 18, 2016 Buy$11.045,00055,220129,250Mar 21, 2016, 12:45 PM
Hatten Sandra LSr. VP, Quality & Reg AffairsMar 18, 2016 Buy$11.013,00033,0303,000Mar 21, 2016, 12:44 PM
STAPLETON CRAIG RDirectorMar 14, 2016 Buy$10.39100,0001,039,400482,450Mar 16, 2016, 04:48 PM
ANDERSON MICHAEL SChief Executive OfficeMar 14, 2016 Buy$9.7310,00097,350124,250Mar 16, 2016, 04:46 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MCHUGH THOMAS SChief Financial Officer01/16/202429,000
McCamish Mark AnthonyDirector12/28/20231,089,750
McCamish Mark AnthonyDirector08/11/2023432,614
MCHUGH THOMAS SChief Financial Officer08/14/202328,900
Glass Geoffrey MichaelDirector08/10/2023187,600
Divis Gregory JChief Executive Officer08/10/2023131,997
Ende Eric JDirector05/18/2023181,100
Palczuk LindaDirector05/09/202336,900
Palczuk LindaDirector12/23/202214,405
MCHUGH THOMAS SChief Financial Officer11/29/202239,000
Ende Eric JDirector11/22/2022156,050
Glass Geoffrey MichaelDirector05/31/202296,300
Glass Geoffrey MichaelDirector06/01/202296,300
Ende Eric JDirector05/31/202232,394
Ende Eric JDirector06/01/202245,496
Palczuk LindaDirector05/27/202216,000
MCHUGH THOMAS SChief Financial Officer05/27/2022106,895
Ende Eric JDirector05/27/202236,747
Divis Gregory JChief Executive Officer05/27/2022102,500
Thornton Peter J.Director05/27/202284,500
MCHUGH THOMAS SChief Financial Officer09/18/202024,000
McCamish Mark AnthonyDirector09/17/2020305,250
McCamish Mark AnthonyDirector09/16/2020679,969
Ende Eric JDirector09/17/202098,376
MCHUGH THOMAS SChief Financial Officer08/28/202050,776
Glass Geoffrey MichaelDirector08/28/202032,560
MCHUGH THOMAS SChief Financial Officer08/13/202077,814
Palczuk LindaDirector08/14/202019,850
Ende Eric JDirector08/13/202038,928
Glass Geoffrey MichaelDirector08/13/202050,440
Glass Geoffrey MichaelDirector08/12/202050,050
Ende Eric JDirector08/12/2020116,355
Divis Gregory JChief Executive Officer08/12/2020101,156
Hatten Sandra LSee Remarks12/12/201922,211
Ende Eric JDirector12/04/201959,700
Palczuk LindaDirector12/03/201944,325
Glass Geoffrey MichaelDirector11/18/201974,850
Glass Geoffrey MichaelDirector11/15/201924,950
DIVIS GREG JChief Executive Officer11/15/201997,470
Ende Eric JDirector11/15/201949,762
KANAN MICHAEL FSee Remarks12/14/201821,022
GUSKY DAVID PController & CAO12/14/20181,656
Hatten Sandra LSee Remarks12/14/20188,183
ANDERSON MICHAEL SChief Executive Officer08/10/201879,953
Hatten Sandra LSee Remarks08/10/201830,859
KANAN MICHAEL FSee Remarks06/26/201811,212
ANDERSON MICHAEL SChief Executive Officer06/26/201815,100
DIVIS GREG JSee Remarks06/26/201896,000
THOMPSON PHILLANDAS T.See Remarks06/26/201857,700
Flynn James E10% Owner06/25/2018683,315
ANDERSON MICHAEL SChief Executive Officer05/24/201819,320
STAPLETON CRAIG RDirector12/15/2017606,970
STAPLETON CRAIG RDirector12/15/2017606,970
STAPLETON CRAIG RDirector12/15/2017606,970
STAPLETON CRAIG RDirector12/15/2017606,970
ANDERSON MICHAEL SChief Executive Officer12/07/201744,295
STAPLETON CRAIG RDirector11/27/20172,377,632
Thornton Peter J.Director09/21/201750,215
Hatten Sandra LSee Remarks09/12/201710,980
Hatten Sandra LSee Remarks09/14/201719,654
Hatten Sandra LSee Remarks09/13/20174,673
Hatten Sandra LSee Remarks09/12/201720,218
THOMPSON PHILLANDAS T.See Remarks09/13/201746,800
STAPLETON CRAIG RDirector09/12/2017190,360
DIVIS GREG JSee Remarks09/12/201798,760
ANDERSON MICHAEL SChief Executive Officer09/12/201739,180
Broadfin Healthcare Master Fund Ltd10% Owner06/23/20171,706,600
Broadfin Healthcare Master Fund Ltd10% Owner06/22/20171,080,000
CERUTTI GUILLAUMEDirector06/15/2017277,818
ANDERSON MICHAEL SChief Executive Officer05/19/201725,000
STAPLETON CRAIG RDirector05/19/201730,473
STAPLETON CRAIG RDirector05/18/2017109,910
STAPLETON CRAIG RDirector05/22/2017164,944
STAPLETON CRAIG RDirector05/17/2017120,393
STAPLETON CRAIG RDirector05/16/201734,700
STAPLETON CRAIG RDirector05/15/20173,110
STAPLETON CRAIG RDirector05/12/201731,060
STAPLETON CRAIG RDirector04/04/2017143,643
STAPLETON CRAIG RDirector11/29/2016108,500
STAPLETON CRAIG RDirector11/28/2016107,370
ANDERSON MICHAEL SChief Executive Officer11/21/201621,274
FILDES FRANCISDirector09/22/2016201,750
ANDERSON MICHAEL SChief Executive Officer09/02/201628,240
STAPLETON CRAIG RDirector09/01/2016135,190
STAPLETON CRAIG RDirector08/26/2016275,140
ANDERSON MICHAEL SChief Executive Officer08/22/201671,479
STAPLETON CRAIG RDirector05/16/201622,339
STAPLETON CRAIG RDirector05/13/2016228,553
ANDERSON MICHAEL SChief Executive Officer05/12/201644,200
THOMPSON PHILLANDAS T.See Remarks03/22/2016111,030
ANDERSON MICHAEL SChief Executive Officer03/18/201655,220
Hatten Sandra LSr. VP, Quality & Reg Affairs03/18/201633,030
STAPLETON CRAIG RDirector03/14/20161,039,400
ANDERSON MICHAEL SChief Executive Office03/14/201697,350
Load More Insider Transactions
FUNDS WITH A POSITION IN AVADEL PHARMACEUTICALS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC4,096,4284.74%No changeOther
BRANDES INVESTMENT PARTNERS, LP1,533,6140.33%5.86%Value
BALYASNY ASSET MANAGEMENT L.P.781,5150.02%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC625,1060.01%-15.4%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.225,0000.00658%-86.96%Other
D. E. SHAW & CO., INC.196,5540.00243%-64.22%Other
GEODE CAPITAL MANAGEMENT, LLC92,5830.00014%-1.93%Other
BLACKROCK INC.81,5320.00003%3.88%Other
ROYCE & ASSOCIATES LP20,9810.00274%NewValue
CHANGE IN SHARES OUTSTANDING FOR AVADEL PHARMACEUTICALS PLC
STOCK BUYBACKS FOR AVADEL PHARMACEUTICALS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
15.71%
1Q
09/30/2023
09/30/2022
48.47%
4Q
09/30/2023
06/30/2022
51.40%
5Q
09/30/2023
03/31/2022
51.94%
6Q
09/30/2023
12/31/2021
52.47%
7Q
09/30/2023
09/30/2021
52.56%
8Q
09/30/2023
06/30/2021
52.82%
9Q
09/30/2023
03/31/2021
52.94%
10Q
09/30/2023
12/31/2020
46.01%
11Q
09/30/2023
09/30/2020
53.54%
12Q
09/30/2023
06/30/2020
27.79%
13Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
15.71%
1Q
09/30/2022
48.47%
4Q
06/30/2022
51.40%
5Q
03/31/2022
51.94%
6Q
12/31/2021
52.47%
7Q
09/30/2021
52.56%
8Q
06/30/2021
52.82%
9Q
03/31/2021
52.94%
10Q
12/31/2020
46.01%
11Q
09/30/2020
53.54%
12Q
06/30/2020
27.79%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVADEL PHARMACEUTICALS PLC
LOADING...